Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Oshiro

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Neuroreport|August 7, 1998
Functional mapping of pain-related activation with echo-planar MRI: significance of the SII-insular regionY Oshiro, N Fuijita, H Tanaka, et al.
Life Sciences|November 2, 1987
Dichloroacetate derivatives. Metabolic effects and pharmacodynamics in normal ratsP W Stacpoole, M G Gonzalez, J Vlasak, et al.
Journal of Medicinal Chemistry|July 1, 1991
Novel cerebroprotective agents with central nervous system stimulating activity. 2. Synthesis and pharmacology of the 1-(acylamino)-7-hydroxyindan derivativesY Oshiro, Y Sakurai, T Tanaka, et al.
Oncology Reports|May 19, 2011
Aggressive angiomyxoma of the inguinal regionT Oshiro, Y Oshiro, H Baba, et al.
Life Sciences|November 6, 2001
Triiodothyronine concomitantly inhibits calcium overload and postischemic myocardial stunning in diabetic ratsY Oshiro, M Shimabukuro, N Takasu, et al.
Human Pathology|December 1, 2001
Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasiaA Sakamoto, Y Oda, Y Oshiro, et al.
Journal of Medicinal Chemistry|July 1, 1991
Novel cerebroprotective agents with central nervous system stimulating activity. 1. Synthesis and pharmacology of 1-amino-7-hydroxyindan derivativesY Oshiro, Y Sakurai, T Tanaka, et al.
Biomedicines|September 28, 2024
Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023Alexander C Martins, Mariana Y Oshiro, Fernando Albericio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2001
Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytomaA Sakamoto, Y Oda, E Itakura, et al.
Histopathology|April 12, 2002
Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysisK Miyajima, Y Oda, Y Oshiro, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Neuroreport|August 7, 1998
Functional mapping of pain-related activation with echo-planar MRI: significance of the SII-insular regionY Oshiro, N Fuijita, H Tanaka, et al.
Life Sciences|November 2, 1987
Dichloroacetate derivatives. Metabolic effects and pharmacodynamics in normal ratsP W Stacpoole, M G Gonzalez, J Vlasak, et al.
Journal of Medicinal Chemistry|July 1, 1991
Novel cerebroprotective agents with central nervous system stimulating activity. 2. Synthesis and pharmacology of the 1-(acylamino)-7-hydroxyindan derivativesY Oshiro, Y Sakurai, T Tanaka, et al.
Oncology Reports|May 19, 2011
Aggressive angiomyxoma of the inguinal regionT Oshiro, Y Oshiro, H Baba, et al.
Life Sciences|November 6, 2001
Triiodothyronine concomitantly inhibits calcium overload and postischemic myocardial stunning in diabetic ratsY Oshiro, M Shimabukuro, N Takasu, et al.
Human Pathology|December 1, 2001
Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasiaA Sakamoto, Y Oda, Y Oshiro, et al.
Journal of Medicinal Chemistry|July 1, 1991
Novel cerebroprotective agents with central nervous system stimulating activity. 1. Synthesis and pharmacology of 1-amino-7-hydroxyindan derivativesY Oshiro, Y Sakurai, T Tanaka, et al.
Biomedicines|September 28, 2024
Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023Alexander C Martins, Mariana Y Oshiro, Fernando Albericio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2001
Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytomaA Sakamoto, Y Oda, E Itakura, et al.
Histopathology|April 12, 2002
Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysisK Miyajima, Y Oda, Y Oshiro, et al.
Pageof 8